Skip to main content
The FiscalWire

XERS

NASDAQ-GS

Xeris Biopharma Holdings, Inc. Common Stock

$15.20
+2.12 (+16.21%)

Key Statistics - XERS

Valuation Measures

MetricCurrent
Market Cap2.78B
Enterprise Value0
Trailing P/E—
Forward P/E37.91
PEG Ratio (5yr expected)—
Price/Sales7.54
Price/Book56.88
EV/Revenue—
EV/EBITDA—

Financial Highlights

Fiscal Year

Fiscal Year Ends—
Most Recent Quarter (mrq)—

Profitability

Profit Margin-1.76%
Operating Margin (ttm)12.70%

Management Effectiveness

Return on Assets (ttm)-1.64%
Return on Equity (ttm)-27.11%

Income Statement

Revenue (ttm)—
Revenue Per Share (ttm)—
Quarterly Revenue Growth (yoy)44.16%
Gross Profit (ttm)—
EBITDA—
Net Income Avi to Common (ttm)—
Diluted EPS (ttm)-0.05
Quarterly Earnings Growth (yoy)1597.14%

Balance Sheet

Total Cash (mrq)—
Total Cash Per Share (mrq)0.72
Total Debt (mrq)—
Total Debt/Equity (mrq)4.63
Current Ratio (mrq)2.15
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)—
Levered Free Cash Flow (ttm)—

Trading Information

Stock Price History

Beta (5Y Monthly)0.77
52 Week Change—
S&P500 52-Week Change—
52 Week High13.74
52 Week Low5.25
50-Day Moving Average0.00
200-Day Moving Average0.00

Share Statistics

Avg Vol (3 month)2.55M
Avg Vol (10 day)0
Shares Outstanding182.57M
Implied Shares Outstanding182.57M
Float173.47M
% Held by Insiders5.05%
% Held by Institutions61.43%
Shares Short—
Short Ratio3.14
Short % of Float4.63%
Short % of Shares Outstanding—
Shares Short (prior month)—

Dividends & Splits

Forward Annual Dividend Rate—
Forward Annual Dividend Yield—
Trailing Annual Dividend Rate—
Trailing Annual Dividend Yield—
5 Year Average Dividend Yield—
Payout Ratio0.00%
Dividend Date—
Ex-Dividend Date—
Last Split Factor—
Last Split Date—